Mars Commits $2M to Boost Healthcare Access for Cocoa Farmers in Côte d'Ivoire

  • Mars Impact Fund awarded $2.07M to Elucid over three years (2026-2029) to expand healthcare access for cocoa-farming families in Côte d'Ivoire.
  • The BLOOM program aims to help up to 12,750 households access national health insurance and co-pay support.
  • Additional $2M in matching funds from Gavi will upgrade rural health facilities and expand vaccination coverage for over 200,000 people.
  • Elucid Santé Côte d'Ivoire will implement the program, focusing on removing healthcare cost barriers and administrative hurdles.

Mars' investment underscores the growing corporate focus on embedding healthcare into agricultural supply chains to ensure sustainable sourcing. By addressing health-related vulnerabilities among cocoa farmers, the company aims to strengthen community resilience—a trend increasingly adopted by multinational firms reliant on raw material supply chains. The $2M grant, combined with Gavi's matching funds, highlights the strategic importance of public-private partnerships in tackling systemic health challenges in rural economies.

Program Scalability
Whether the BLOOM model can be replicated across other agricultural supply chains and regions.
Impact Measurement
How Elucid and Mars will track and report on health outcomes and economic resilience improvements.
Supply Chain Resilience
The long-term effect of improved farmer health on cocoa supply chain stability and Mars' sourcing costs.